» Authors » F C G J Sweep

F C G J Sweep

Explore the profile of F C G J Sweep including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 705
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Reinema F, Hudson N, Adema G, Peeters W, Neuzil J, Stursa J, et al.
Radiother Oncol . 2024 Aug; 200:110503. PMID: 39186982
Background And Purpose: Radiotherapy (RT) is an integral treatment part for patients with head and neck squamous cell carcinoma (HNSCC), but radioresistance remains a major issue. Here, we use MitoTam,...
2.
Reinema F, Kaanders J, Peeters W, Adema G, Sweep F, Bussink J, et al.
Clin Transl Radiat Oncol . 2024 Jan; 45:100726. PMID: 38292333
Background And Purpose: Radiotherapy (RT) is a mainstay component of treatment for patients with head and neck squamous cell carcinoma (HNSCC), but responses vary. As RT relies upon oxidative damage,...
3.
Reinema F, Sweep F, Adema G, Peeters W, Martens J, Bussink J, et al.
Cancer Metab . 2023 Feb; 11(1):3. PMID: 36755288
Background: Recently, we reported that tamoxifen-resistant (TAM-R) breast cancer cells are cross-resistant to irradiation. Here, we investigated the mechanisms associated with tamoxifen-induced radioresistance, aiming to prevent or reverse resistance and...
4.
Tekampe J, van Middendorp H, Sweep F, Roerink S, Hermus A, Evers A
Pilot Feasibility Stud . 2019 Jan; 5:9. PMID: 30680223
Background: Conditioning of physiological responses can be achieved by repeatedly pairing a previously neutral conditioned stimulus with the administration of a pharmacologically salient unconditioned stimulus. This type of conditioning has...
5.
Eysbouts Y, Ottevanger P, Massuger L, IntHout J, Short D, Harvey R, et al.
Ann Oncol . 2017 May; 28(8):1856-1861. PMID: 28459944
Background: Worldwide introduction of the International Fedaration of Gynaecology and Obstetrics (FIGO) 2000 scoring system has provided an effective means to stratify patients with gestational trophoblastic neoplasia to single- or...
6.
Eysbouts Y, Massuger L, IntHout J, Lok C, Sweep F, Ottevanger P
Gynecol Oncol . 2017 Apr; 145(3):536-542. PMID: 28390821
Background: Despite the undoubted effectiveness of chemotherapeutic treatment in gestational trophoblastic neoplasia (GTN), problems related to toxicity of chemotherapy and chemo-resistant disease have led to reconsideration of the use of...
7.
van den Reek J, Menting S, Janssen W, Dhaliwal R, Heijboer A, van Herwaarden A, et al.
Br J Dermatol . 2017 Jan; 177(5):1454-1457. PMID: 28112796
No abstract available.
8.
Eysbouts Y, Bulten J, Ottevanger P, Thomas C, Ten Kate-Booij M, van Herwaarden A, et al.
Gynecol Oncol . 2015 Nov; 140(1):70-5. PMID: 26586414
Background: Gestational trophoblastic disease (GTD) represents a heterogeneous group of disorders. Wide variations in incidence rates are reported worldwide, probably explained by a lack of centralized databases and heterogeneity in...
9.
Pijnenburg-Kleizen K, Engels M, Mooij C, Griffin A, Krone N, Span P, et al.
Endocrinology . 2015 Jul; 156(10):3504-10. PMID: 26207344
Patients with congenital adrenal hyperplasia (CAH) are often clinically less severely affected by cortisol deficiency than anticipated from their enzymatic defect. We hypothesize that adrenal steroid hormone precursors that accumulate...
10.
Rao J, Engelke U, Sweep F, Pacak K, Kusters B, Goudswaard A, et al.
J Clin Endocrinol Metab . 2014 Dec; 100(2):E214-22. PMID: 25459911
Context And Objective: Pheochromocytomas and paragangliomas (PGLs) are neuroendocrine tumors of sympathetic or parasympathetic paraganglia. Nearly 40% of PGLs are caused by germline mutations. The present study investigated the effect...